Effect of growth hormone therapy in growth hormone-deficient children on cytochrome P-450-dependent 3-N-demethylation of caffeine as measured by the caffeine 13CO2 breath test
- PMID: 2496962
Effect of growth hormone therapy in growth hormone-deficient children on cytochrome P-450-dependent 3-N-demethylation of caffeine as measured by the caffeine 13CO2 breath test
Abstract
In 6 growth hormone-deficient children, we have demonstrated that 3-N-demethylation of caffeine as measured by the 13CO2 caffeine breath test is decreased following 1 month of growth hormone therapy (8.4 +/- 1.0 vs. 6.8 +/- 1.2% 13C/2 h after treatment). These findings could be of clinical importance. The initiation of growth hormone therapy in growth hormone-deficient children could alter the clearance of drugs metabolized through the mixed-function oxidase pathway given for concurrent conditions, and necessitate adjustment of the therapeutic regimen.
Similar articles
-
CO2 breath tests using 14C-caffeine, 14C-methacetin and 14C-phenacetin for assessing postnatal development of monooxygenase activities in rats and marmosets.Dev Pharmacol Ther. 1991;16(3):164-75. Dev Pharmacol Ther. 1991. PMID: 1914790
-
The CO2 breath tests as monitors of the cytochrome P450 dependent mixed function monooxygenase system.Prog Clin Biol Res. 1983;135:119-45. Prog Clin Biol Res. 1983. PMID: 6420801 Review.
-
Maturation of caffeine N-demethylation in infancy: a study using the 13CO2 breath test.Pediatr Res. 1988 Jun;23(6):632-6. doi: 10.1203/00006450-198806000-00021. Pediatr Res. 1988. PMID: 3134644
-
The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.Drug Metab Dispos. 1985 Mar-Apr;13(2):156-62. Drug Metab Dispos. 1985. PMID: 2859162
-
[Use of the labelling of drugs with stable isotopes in clinical pharmacology in children].Arch Fr Pediatr. 1989 Mar;46(3):223-8. Arch Fr Pediatr. 1989. PMID: 2660770 Review. French.
Cited by
-
Effects of growth hormone deficiency and rhGH replacement therapy on the 6beta-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children.Eur J Clin Pharmacol. 2004 Oct;60(8):559-64. doi: 10.1007/s00228-004-0806-4. Epub 2004 Sep 7. Eur J Clin Pharmacol. 2004. PMID: 15365655
-
Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients.Eur J Clin Pharmacol. 2007 Jan;63(1):43-50. doi: 10.1007/s00228-006-0224-x. Epub 2006 Nov 21. Eur J Clin Pharmacol. 2007. PMID: 17119944
-
Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test.Br J Clin Pharmacol. 1994 Dec;38(6):573-6. doi: 10.1111/j.1365-2125.1994.tb04399.x. Br J Clin Pharmacol. 1994. PMID: 7888295 Free PMC article. Clinical Trial.
-
Drug trials in children: problems and the way forward.Br J Clin Pharmacol. 2000 Feb;49(2):93-7. doi: 10.1046/j.1365-2125.2000.00125.x. Br J Clin Pharmacol. 2000. PMID: 10671901 Free PMC article. Review. No abstract available.
-
Lack of effect of growth hormone replacement therapy on CYP1A2 and xanthine oxidase activities in growth hormone-deficient children.Eur J Clin Pharmacol. 2006 Feb;62(2):123-7. doi: 10.1007/s00228-005-0082-y. Epub 2006 Jan 12. Eur J Clin Pharmacol. 2006. PMID: 16408225
MeSH terms
Substances
LinkOut - more resources
Medical